Liquiem Scientific BV Expands into China to Offer Comprehensive Clinical Trial Services

Liquiem Scientific BV, a leading provider of global clinical trial solutions, is proud to announce its expansion into the Chinese market. As part of this strategic move, the company is set to offer a suite of services tailored to meet the growing demand for advanced clinical trials in China. The expansion includes international storage, comparator medicine sourcing, and a range of Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services.

The entry into China marks a significant milestone for Liquiem Scientific BV as it continues to grow its global footprint. China’s clinical trial market is rapidly expanding, driven by increasing investments in biopharmaceutical research and development, regulatory improvements, and the country’s commitment to innovation in healthcare. Recognizing these opportunities, Liquiem Scientific BV is bringing its world-class infrastructure and expertise to support the needs of local and international pharmaceutical companies operating in China. Key Services Include: 1. International Storage: Liquiem Scientific BV offers state-of-the-art storage solutions that comply with global regulatory standards. With strategically located facilities worldwide, including new capabilities in China, the company ensures seamless management of clinical trial materials across borders.
2. Comparator Medicines Sourcing: Through its extensive global network, Liquiem Scientific BV provides high-quality comparator medicines, helping clients navigate the complexities of sourcing critical medications required for their trials.
3. CRO and CDMO Services: Liquiem Scientific BV delivers comprehensive clinical trial support, ranging from protocol development, clinical monitoring, and regulatory consulting to specialized manufacturing services. The company’s expertise ensures that clients can effectively execute trials, from early-stage research to late-phase studies, with a trusted partner. Expanding into the dynamic Chinese market, which plays a crucial role in global clinical research bringing our proven services and expertise to China, we aim to help our clients accelerate innovation and deliver life-saving therapies more efficiently Our presence in China will strengthen our ability to offer seamless global solutions, enabling us to better serve pharmaceutical companies and researchers. The expansion aligns with Liquiem Scientific BV’s mission to enhance the efficiency and quality of clinical trials globally, while supporting clients in overcoming regulatory and logistical challenges in new markets. With an experienced local team and a deep understanding of the Chinese regulatory landscape, Liquiem Scientific BV is committed to driving success in this highly competitive environment.